Table 2.
Summary Estimates
| Study | Summary sensitivity | Summary specificity | Summary positive likelihood ratio | Summary negative likelihood ratio |
|---|---|---|---|---|
| GAST with testosterone suppression | 10% (95% CI, 1.1%-46.7%) | 100% (95% CI, 0%-100%) | - infinity | 0.9 (95% CI, 0.714-1.086) |
| SOAVC (Best-case scenario) | 100% (95% CI, 0%-100%) | 100% (95% CI, 0.3%-100%) | 12 216.53 (95% CI, −175 765 to 200 197.7) | 0 (95% CI, 0-0) |
| SOAVC (Worst-case scenario) | 100% (95% CI, 1.7%-100%) | 100% (95% CI, 9%-100%) | 74 480.42 (95% CI, −933 229 to 1 082 190) | 0 (95% CI, −0.003 to 0.004) |
Abbreviations: GAST, GnRH analogue stimulation test; SOAVC, selective ovarian and adrenal vein catheterization.